Anti-MMP9 antibody [RM1020] (Ab283575)
CLG4B, MMP9, Matrix metalloproteinase-9, MMP-9, 92 kDa gelatinase, 92 kDa type IV collagenase, Gelatinase B, GELB, Clg4b, Mmp9, Matrix metalloproteinase-9, MMP-9, 92 kDa gelatinase, 92 kDa type IV collagenase, Gelatinase B, GELB
详细信息
背景信息
What is this antibody validated in? Anti-MMP9 antibody [RM1020] (ab283575) is a rabbit recombinant recombinant multiclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunohistochemistry (IHC-Fr), Immunocytochemistry/immunofluorescence (ICC/IF), ELISA in Human, Mouse, Rat samples. What is the molecular weight of MMP9? Anti-MMP9 [RM1020] (ab283575) specifically detects a band for MMP9 (UniProt: P14780) at a molecular weight of 78kDa. Trusted by the scientific community Anti-MMP9 [RM1020] (ab283575) was first used in a scientific publication in 2021 and has been cited over 30 times in peer-reviewed journals. Specificity confirmed The specificity of Anti-MMP9 antibody [RM1020] (ab283575) has been confirmed by Western blot testing in MMP9 Knockout A549 cell line. Other related products We have a range of other formats of antibody clone [RM1020] also available for your convenience: ab283575, Carrier free - ab283594 What are recombinant multiclonals? Recombinant multiclonals are a mixture of recombinant antibodies co-expressed from a library of heavy and light chains. They offer several advantages including - The sensitivity of polyclonal antibodies by recognising multiple epitopes - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production View our range of recombinant multiclonal antibodies. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 20µl. Discover our selection of trial-size antibodies.
文献引用 (101)
Ixazomib triggers autophagic degradation of MUC5AC/integrin-β4 and inhibits non-small cell lung cancer progression.
伊沙佐米可触发 MUC5AC/整合素-β4 的自噬降解,并抑制非小细胞肺癌的进展。
Gut Metabolite Indoleacrylic Acid Suppresses Osteoclast Formation by AHR mediated NF-κB Signaling Pathway.
肠道代谢产物吲哚丙烯酸通过 AHR 介导的 NF-κB 信号通路抑制破骨细胞形成。
Integrated Serum Pharmacochemistry, Network Pharmacology, and Transcriptomics Reveal the Mechanisms and Active Constituents of Qingfei Huoxue Decoction Against Bleomycin-Induced Pulmonary Fibrosis.
血清药理化学、网络药理学和转录组学的综合分析揭示了清肺活血汤对抗博来霉素诱导的肺纤维化的机制和活性成分。
Pachymic Acid Targets PI3K/Akt Signaling Pathway to Attenuate tPA-Induced Hemorrhagic Transformation After Ischemic Stroke.
帕奇米酸靶向 PI3K/Akt 信号通路以减弱缺血性卒中后 tPA 诱导的出血性转化。
BMSC-Derived Exosomal miR-21a-5p Ameliorates Blood-Brain Barrier Injury and Hemorrhagic Transformation.
BMSC来源的外泌体miR-21a-5p可改善血脑屏障损伤和出血性转化。
miR-18a-5p promotes phenotypic transformation of airway smooth muscle cells by targeting SPRY1 to activate the RAS-MAPK pathway.
miR-18a-5p 通过靶向 SPRY1 激活 RAS-MAPK 通路,促进气道平滑肌细胞的表型转化。
Virus-inspired lipopeptide-derived nucleic acid delivery to cartilage for osteoarthritis therapy.
病毒启发式脂肽衍生核酸向软骨递送治疗骨关节炎。
ZBP1-mediated PANoptosis is a crucial lethal form in diverse keratinocyte death modalities in UVB-induced skin injury
ZBP1 介导的 PANoptosis 是 UVB 引起的皮肤损伤中多种角质形成细胞死亡方式中一种至关重要的致死形式
Transcriptome reveals the landscape of alveolar macrophages exposed to combined hypoxia with cigarette smoke extract
转录组揭示了暴露于缺氧和香烟烟雾提取物联合作用下的肺泡巨噬细胞的图谱
CAF-derived exosomes drive the FGF4/SHH feedback loop by encapsulating GREM1 in non-small cell lung cancer
CAF来源的外泌体通过包裹GREM1驱动非小细胞肺癌中的FGF4/SHH反馈环路
- 1
- 2
- 3
- 4
- 5
- 6
- 11